Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer
David S Binns, Andrea Pirzkall, Wei Yu, Jason Callahan, Linda Mileshkin, Peter Conti, Andrew M Scott, David Macfarlane, Bernard M Fine, Rodney J Hicks
European Journal of Nuclear Medicine and Molecular Imaging | SPRINGER | Published : 2011
This work was supported financially by Genentech, Inc., South San Francisco, CA, USA. Drs. Pirzkall, Yu and Fine are employees at Genentech, Inc., and own stock with F. Hoffmann-La Roche, Ltd.